Story thread · 2 reports / 2 sources

Icotrokinra Shows Sustained Psoriasis Benefits at 1 Year

medscape.com · 6h · first report

The once-daily IL-23-targeted pill showed high rates of skin clearance and itch improvement in adults with moderate-to-severe plaque psoriasis. Medscape Medical News

The coverage

  1. Ascletis challenges psoriasis field with pill; Invivyd plans Covid filing

    endpts.com · 2h

The conversation · 0

Sign in to join the conversation.

No comments yet — start the thread.